292 related articles for article (PubMed ID: 16283863)
1. Economic burden of patients with anemia in selected diseases.
Ershler WB; Chen K; Reyes EB; Dubois R
Value Health; 2005; 8(6):629-38. PubMed ID: 16283863
[TBL] [Abstract][Full Text] [Related]
2. Economic burden of anemia in an insured population.
Nissenson AR; Wade S; Goodnough T; Knight K; Dubois RW
J Manag Care Pharm; 2005 Sep; 11(7):565-74. PubMed ID: 16137214
[TBL] [Abstract][Full Text] [Related]
3. The economic burden of anemia in cancer patients receiving chemotherapy.
Lyman GH; Berndt ER; Kallich JD; Erder MH; Crown WH; Long SR; Lee H; Song X; Finkelstein SN
Value Health; 2005; 8(2):149-56. PubMed ID: 15804323
[TBL] [Abstract][Full Text] [Related]
4. Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease.
Maddux FW; Shetty S; del Aguila MA; Nelson MA; Murray BM
Ann Pharmacother; 2007 Nov; 41(11):1761-9. PubMed ID: 17895328
[TBL] [Abstract][Full Text] [Related]
5. Medical costs of untreated anemia in elderly patients with predialysis chronic kidney disease.
Lefebvre P; Duh MS; Buteau S; Bookhart B; Mody SH
J Am Soc Nephrol; 2006 Dec; 17(12):3497-502. PubMed ID: 17082245
[TBL] [Abstract][Full Text] [Related]
6. [Importance of comorbidities in the anemia of COPD: Economic implications and 3-year survival analysis].
Menou A; Pain M; Pivette J; Chenivesse C; Magnan A; Chambellan A
Rev Mal Respir; 2016 Sep; 33(7):565-72. PubMed ID: 26803449
[TBL] [Abstract][Full Text] [Related]
7. The direct costs of untreated comorbid insomnia in a managed care population with major depressive disorder.
Asche CV; Joish VN; Camacho F; Drake CL
Curr Med Res Opin; 2010 Aug; 26(8):1843-53. PubMed ID: 20515321
[TBL] [Abstract][Full Text] [Related]
8. The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation.
Park KT; Ehrlich OG; Allen JI; Meadows P; Szigethy EM; Henrichsen K; Kim SC; Lawton RC; Murphy SM; Regueiro M; Rubin DT; Engel-Nitz NM; Heller CA
Inflamm Bowel Dis; 2020 Jan; 26(1):1-10. PubMed ID: 31112238
[TBL] [Abstract][Full Text] [Related]
9. Anemia in chronic obstructive pulmonary disease: epidemiology and economic implications.
Shorr AF; Doyle J; Stern L; Dolgitser M; Zilberberg MD
Curr Med Res Opin; 2008 Apr; 24(4):1123-30. PubMed ID: 18331668
[TBL] [Abstract][Full Text] [Related]
10. Economic burden of non-cystic fibrosis bronchiectasis in the first year after diagnosis from a US health plan perspective.
Joish VN; Spilsbury-Cantalupo M; Operschall E; Luong B; Boklage S
Appl Health Econ Health Policy; 2013 Jun; 11(3):299-304. PubMed ID: 23580074
[TBL] [Abstract][Full Text] [Related]
11. Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patients.
Michaud K; Messer J; Choi HK; Wolfe F
Arthritis Rheum; 2003 Oct; 48(10):2750-62. PubMed ID: 14558079
[TBL] [Abstract][Full Text] [Related]
12. Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population.
Schwab P; Dhamane AD; Hopson SD; Moretz C; Annavarapu S; Burslem K; Renda A; Kaila S
Int J Chron Obstruct Pulmon Dis; 2017; 12():735-744. PubMed ID: 28260880
[TBL] [Abstract][Full Text] [Related]
13. The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population.
Menzin J; Boulanger L; Marton J; Guadagno L; Dastani H; Dirani R; Phillips A; Shah H
Respir Med; 2008 Sep; 102(9):1248-56. PubMed ID: 18620852
[TBL] [Abstract][Full Text] [Related]
14. Shifting Cost-drivers of Health Care Expenditures in Inflammatory Bowel Disease.
Click B; Lopez R; Arrigain S; Schold J; Regueiro M; Rizk M
Inflamm Bowel Dis; 2020 Jul; 26(8):1268-1275. PubMed ID: 31671186
[TBL] [Abstract][Full Text] [Related]
15. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
[TBL] [Abstract][Full Text] [Related]
16. The economic burden of congestive heart failure in a managed care population.
Xuan J; Duong PT; Russo PA; Lacey MJ; Wong B
Am J Manag Care; 2000 Jun; 6(6):693-700. PubMed ID: 10977478
[TBL] [Abstract][Full Text] [Related]
17. Economic Burden of COPD in the Presence of Comorbidities.
Mannino DM; Higuchi K; Yu TC; Zhou H; Li Y; Tian H; Suh K
Chest; 2015 Jul; 148(1):138-150. PubMed ID: 25675282
[TBL] [Abstract][Full Text] [Related]
18. Assessing the costs of chronic obstructive pulmonary disease: the state medicaid perspective.
Marton JP; Boulanger L; Friedman M; Dixon D; Wilson J; Menzin J
Respir Med; 2006 Jun; 100(6):996-1005. PubMed ID: 16288858
[TBL] [Abstract][Full Text] [Related]
19. Is rheumatoid arthritis care more costly when provided by rheumatologists compared with generalists?
Gabriel SE; Wagner JL; Zinsmeister AR; Scott CG; Luthra HS
Arthritis Rheum; 2001 Jul; 44(7):1504-14. PubMed ID: 11465700
[TBL] [Abstract][Full Text] [Related]
20. Hidden cost of rheumatoid arthritis (RA): estimating cost of comorbid cardiovascular disease and depression among patients with RA.
Joyce AT; Smith P; Khandker R; Melin JM; Singh A
J Rheumatol; 2009 Apr; 36(4):743-52. PubMed ID: 19228658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
